{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:11:53Z","timestamp":1791087113758,"version":"4.1.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We investigated the relationship between the reversibility of airflow limitation, the concentration of nitric oxide (NO) in exhaled air, and the inflammatory cells in the sputum of patients with stable chronic obstructive pulmonary disease (COPD). We examined nine normal healthy control subjects and 20 nonatopic patients with COPD. Ten patients had no reversibility of airflow limitation (increase in FEV1 of &amp;lt; 12% and &amp;lt; 200 ml after 200 \u03bc g of inhaled salbutamol), and 10 patients had partial reversibility of airflow limitation (increase in FEV1 of &amp;lt; 12% but &amp;gt; 200 ml after 200 \u03bc g of inhaled salbutamol). Exhaled NO levels were higher in COPD patients with partial reversibility of airflow limitation than in those with no reversibility of airflow limitation (median 24 [interquartile range 15.3 to 32] ppb versus 8.9 [4.6 to 14.7] ppb; p &amp;lt; 0.01). Compared with healthy control subjects, only COPD patients with partial reversibility of airflow limitation had increased concentrations of sputum eosinophils. We conclude that, in patients with stable COPD, even a partial bronchodilator response to inhaled salbutamol is associated with increased exhaled NO and sputum eosinophilia, suggesting that these patients may have a different response to treatment than do those without reversible airflow limitation.<\/jats:p>","DOI":"10.1164\/ajrccm.162.5.9910112","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T14:25:08Z","timestamp":1365085508000},"page":"1773-1777","source":"Crossref","is-referenced-by-count":209,"title":["Partial Reversibility of Airflow Limitation and Increased Exhaled NO and Sputum Eosinophilia in Chronic Obstructive Pulmonary Disease"],"prefix":"10.1093","volume":"162","author":[{"given":"ALBERTO","family":"PAPI","sequence":"first","affiliation":[{"name":"Research Center on Asthma and COPD, University of Ferrara, Ferrara, Italy; Institute of Occupational Medicine, University of Padua, Padua; and University of Modena, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MICAELA","family":"ROMAGNOLI","sequence":"additional","affiliation":[{"name":"Research Center on Asthma and COPD, University of Ferrara, Ferrara, Italy; Institute of Occupational Medicine, University of Padua, Padua; and University of Modena, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SIMONETTA","family":"BARALDO","sequence":"additional","affiliation":[{"name":"Research Center on Asthma and COPD, University of Ferrara, Ferrara, Italy; Institute of Occupational Medicine, University of Padua, Padua; and University of Modena, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FAUSTO","family":"BRACCIONI","sequence":"additional","affiliation":[{"name":"Research Center on Asthma and COPD, University of Ferrara, Ferrara, Italy; Institute of Occupational Medicine, University of Padua, Padua; and University of Modena, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"IPPOLITO","family":"GUZZINATI","sequence":"additional","affiliation":[{"name":"Research Center on Asthma and COPD, University of Ferrara, Ferrara, Italy; Institute of Occupational Medicine, University of Padua, Padua; and University of Modena, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MARINA","family":"SAETTA","sequence":"additional","affiliation":[{"name":"Research Center on Asthma and COPD, University of Ferrara, Ferrara, Italy; Institute of Occupational Medicine, University of Padua, Padua; and University of Modena, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ADALBERTO","family":"CIACCIA","sequence":"additional","affiliation":[{"name":"Research Center on Asthma and COPD, University of Ferrara, Ferrara, Italy; Institute of Occupational Medicine, University of Padua, Padua; and University of Modena, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LEONARDO M.","family":"FABBRI","sequence":"additional","affiliation":[{"name":"Research Center on Asthma and COPD, University of Ferrara, Ferrara, Italy; Institute of Occupational Medicine, University of Padua, Padua; and University of Modena, Modena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2000,11,1]]},"reference":[{"key":"2026032708341814400_B1","first-page":"S77","article-title":"Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease: American Thoracic Society.","volume":"152","author":"Celli","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032708341814400_B2","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1183\/09031936.95.08081398","article-title":"Optimal assessment and management of chronic obstructive pulmonary disease (COPD): the European Respiratory Society Task Force.","volume":"8","author":"Siafakas","year":"1995","journal-title":"Eur Respir J"},{"key":"2026032708341814400_B3","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJM199211123272003","article-title":"A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease: Dutch Chronic Non- Specific Lung Disease Study Group.","volume":"327","author":"Kerstjens","year":"1992","journal-title":"N Engl J Med"},{"key":"2026032708341814400_B4","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1164\/ajrccm.155.2.9032192","article-title":"Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD.","volume":"155","author":"Keatings","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032708341814400_B5","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1164\/ajrccm.155.5.9154853","article-title":"Corticosteroid reversibility in COPD is related to features of asthma.","volume":"155","author":"Chanez","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032708341814400_B6","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1378\/chest.115.3.697","article-title":"Eosinophilic inflammation in the airway is related to glucocorticoid reversibility in patients with pulmonary emphysema.","volume":"115","author":"Fujimoto","year":"1999","journal-title":"Chest"},{"key":"2026032708341814400_B7","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0091-6749(93)90078-T","article-title":"Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease.","volume":"92","author":"Lacoste","year":"1993","journal-title":"J Allergy Clin Immunol"},{"key":"2026032708341814400_B8","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1183\/09031936.98.12061248","article-title":"Can exhaled NO be used as a marker of airway inflammation?","volume":"12","author":"Hedenstierna","year":"1998","journal-title":"Eur Respir J"},{"key":"2026032708341814400_B9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/thx.51.3.233","article-title":"Exhaled nitric oxide: a new lung function test.","volume":"51","author":"Barnes","year":"1996","journal-title":"Thorax"},{"key":"2026032708341814400_B10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/thx.53.2.91","article-title":"Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma.","volume":"53","author":"Jatakanon","year":"1998","journal-title":"Thorax"},{"key":"2026032708341814400_B11","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1164\/ajrccm.157.3.97-05009","article-title":"Exhaled nitric oxide in chronic obstructive pulmonary disease.","volume":"157","author":"Maziak","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032708341814400_B12","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/thx.54.7.572","article-title":"de'Munari E, Pesci A. Increased exhaled nitric oxide in patients with stable chronic obstructive pulmonary disease.","volume":"54","author":"Corradi","year":"1999","journal-title":"Thorax"},{"key":"2026032708341814400_B13","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1164\/ajrccm.153.5.8630613","article-title":"Measurement of exhaled nitric oxide by three different techniques.","volume":"153","author":"Robbins","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032708341814400_B14","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1183\/09031936.98.12040816","article-title":"Nitric oxide measured with single-breath and tidal-breathing methods in asthma and COPD.","volume":"12","author":"Rutgers","year":"1998","journal-title":"Eur Respir J"},{"key":"2026032708341814400_B15","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1136\/thx.54.7.576","article-title":"Markers of nitric oxide metabolism in sputum and exhaled air are not increased in chronic obstructive pulmonary disease.","volume":"54","author":"Rutgers","year":"1999","journal-title":"Thorax"},{"key":"2026032708341814400_B16","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1046\/j.1365-2222.1998.00342.x","article-title":"Increased production of endogenous nitric oxide in patients with bronchial asthma and chronic obstructive pulmonary disease.","volume":"28","author":"Kanazawa","year":"1998","journal-title":"Clin Exp Allergy"},{"key":"2026032708341814400_B17","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1164\/ajrccm\/143.6.1212","article-title":"Spirometry: quality control and reproducibility criteria.","volume":"143","author":"Crapo","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"2026032708341814400_B18"},{"key":"2026032708341814400_B19","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.4049\/jimmunol.162.7.3926","article-title":"Antibodies to the IL-12 receptor beta 2 chain mark human Th1 but not Th2 cells in vitro and in vivo.","volume":"162","author":"Rogge","year":"1999","journal-title":"J Immunol"},{"key":"2026032708341814400_B20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1183\/09041950.005s1693","article-title":"Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society.","volume":"16","author":"Quanjer","year":"1993","journal-title":"Eur Respir J Suppl"},{"key":"2026032708341814400_B21","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1164\/ajrccm.153.6.8665033","article-title":"Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract.","volume":"153","author":"Kharitonov","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032708341814400_B22","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1183\/09031936.97.10071683","article-title":"Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force.","volume":"10","author":"Kharitonov","year":"1997","journal-title":"Eur Respir J"},{"key":"2026032708341814400_B23","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1365-201X.1997.00101.x","article-title":"Nitric oxide from the human respiratory tract efficiently quantified by standardized single breath measurements.","volume":"159","author":"Hogman","year":"1997","journal-title":"Acta Physiol Scand"},{"key":"2026032708341814400_B24","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1164\/ajrccm.152.6.8520757","article-title":"Comparison of leukocyte counts in sputum, bronchial biopsies, and bronchoalveolar lavage.","volume":"152","author":"Maestrelli","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032708341814400_B25"},{"key":"2026032708341814400_B26","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1164\/arrd.1986.133.1.14","article-title":"Bronchodilator response in chronic obstructive pulmonary disease.","volume":"133","author":"Anthonisen","year":"1986","journal-title":"Am Rev Respir Dis"},{"key":"2026032708341814400_B27","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7326\/0003-4819-114-3-216","article-title":"Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease: a meta-analysis.","volume":"114","author":"Callahan","year":"1991","journal-title":"Ann Intern Med"},{"key":"2026032708341814400_B28"},{"key":"2026032708341814400_B29"},{"key":"2026032708341814400_B30","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/thx.53.10.881","article-title":"Pagani M, Ambrosino N. Endogenous nitric oxide in patients with stable COPD: correlates with severity of disease.","volume":"53","author":"Clini","year":"1998","journal-title":"Thorax"},{"key":"2026032708341814400_B31","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1096\/fasebj.12.11.929","article-title":"Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid.","volume":"12","author":"Saleh","year":"1998","journal-title":"FASEB J"},{"key":"2026032708341814400_B32","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/thx.54.5.403","article-title":"Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma.","volume":"54","author":"van Rensen","year":"1999","journal-title":"Thorax"},{"key":"2026032708341814400_B33","first-page":"29","article-title":"Airway pathology of COPD compared with asthma.","volume":"7","author":"Saetta","year":"1997","journal-title":"Eur Respir Rev"},{"key":"2026032708341814400_B34","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1034\/j.1399-3003.1999.13d24.x","article-title":"The cellular composition of induced sputum in chronic obstructive pulmonary disease.","volume":"13","author":"Peleman","year":"1999","journal-title":"Eur Respir J"},{"key":"2026032708341814400_B35","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1164\/ajrccm.158.5.9804028","article-title":"Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis.","volume":"158","author":"Pizzichini","year":"1998","journal-title":"Am J Respir Crit Care Med"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/162\/5\/1773\/67543995\/ajrccm_162_5_1773.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/162\/5\/1773\/67543995\/ajrccm_162_5_1773.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:34:26Z","timestamp":1774614866000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/162\/5\/1773\/8541104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11,1]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2000,11,1]]},"published-print":{"date-parts":[[2000,11,1]]}},"URL":"https:\/\/doi.org\/10.1164\/ajrccm.162.5.9910112","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2000,11]]},"published":{"date-parts":[[2000,11,1]]}}}